Autoimmune therapy(Selecta Biosciences)

N/A

Report date: 2025/05/14 14:17:00

Base Information

Drug NameAutoimmune therapy(Selecta Biosciences)
Drug Alias NameImmTOR PBC
ClassificationBiologics
Mechanisms of ActionImmunosuppressantsDendritic cells stimulantsT lymphocytes inhibitors +[4] 
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsLiver Cirrhosis, Biliary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelecta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSelecta Biosciences Inc
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis, Biliary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A